Latest News about Phase 1 Trial
Recent news which mentions Phase 1 Trial
FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
January 24, 2022
From Benzinga
FDA Gives Nod To TScan Therapeutics' Early-Stage Trial Of TSC-100 In Hematologic Malignancies
January 24, 2022
Tickers
TCRX
From Benzinga
Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers
January 24, 2022
Tickers
HCWB
From Benzinga
Regulus Therapeutics Moves Forward With Next-Gen Compound, RGLS8429 In Kidney Disorder
January 21, 2022
Tickers
RGLS
From Benzinga
FDA Lifts Partial Hold On Kura Oncology's Early-Stage Leukemia Trial
January 21, 2022
Tickers
KURA
From Benzinga
FDA Clears Turning Point's IND For Elzovantinib + Aumolertinib Combo Regime In Lung Cancer Setting
January 20, 2022
From Benzinga
Seagen's SEA-CD40 Combo Regime Shows Preliminary Antitumor Activity In Pancreatic Cancer
January 19, 2022
From Benzinga
Cardiff Oncology Slumps On New Data From Lead Program In Metastatic Colorectal Cancer
January 19, 2022
Tickers
CRDF
From Benzinga
Vaxcyte Raises $100M Via Equity To Fund Development Of Lead Pneumococcal Vaccine Candidate
January 13, 2022
Tickers
PCVX
From Benzinga
Galmed's Potential Ulcerative Colitis Candidate Shows Encouraging Action In Early Study
January 10, 2022
Tickers
GLMD
From Benzinga
Anavex Life's Neurodegenerative Disease Candidate Meets Primary Endpoint In Early-Stage Study
January 10, 2022
Tickers
AVXL
From Benzinga
Edgewise Therapeutics Shares Jump After Positive Data On Becker Muscular Dystrophy Study
January 05, 2022
Tickers
EWTX
From Benzinga
From Benzinga
Mereo BioPharma's Alvelestat Shows Improvement In COVID-19 Severity
December 22, 2021
Tickers
MREO
From Benzinga
Alzamend Neuro Shares Are Trading Higher After Encourage Early-Stage Data From Alzheimer's Candidate
December 17, 2021
Tickers
ALZN
From Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
December 16, 2021
Tickers
QURE
From Benzinga
From Benzinga
Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
December 14, 2021
Tickers
APTO
From Benzinga
Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial
December 14, 2021
Tickers
SNDX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.